Clinical trials · Washington, D.C., DC
Alcoholism clinical trials in Washington, D.C.
We’re tracking 43 recruiting alcoholism studies with a site in or near Washington, D.C. — including Phase 1, Phase 1/Phase 2, Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Washington, D.C.
- NCT07428538RecruitingPhase 3
Testing larsucosterol for severe alcohol-related hepatitis
This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06303778Recruiting
App and medication study to reduce heavy drinking
This study tests if using a smartphone app along with medication can help Veterans reduce heavy drinking. You will be randomly assigned to one of two groups to see which approach works better.
Washington D.C., District of ColumbiaAges 18–80 - NCT06684483Recruiting
Heavy alcohol use and your mouth health
This study looks at how heavy alcohol use affects your saliva and mouth health. It compares people with alcohol use disorder to healthy volunteers to see if the heavy drinking changes the mouth's natural defenses.
Bethesda, MarylandAges 18–100 - NCT02535702Recruiting
Brain scan study to measure addiction biology
This study uses brain imaging (MRI) and tasks to better understand what’s happening in the brain in addiction. It may help researchers improve how addiction is studied and measured using brain-based methods.
Bethesda, MarylandAges 18 years+ - NCT04946851Enrolling by invitation
Alcohol use study for adults who join the NIAAA screening
This study uses a brain-and-behavior “assessment” (neuroclinical testing) to better understand addiction. You may be tested only if you are an adult and are enrolled in the NIAAA screening program, and you cannot join if you are acutely intoxicated.
Bethesda, MarylandAges 18–99 - NCT03884075RecruitingPhase 2
Semaglutide study for fatty liver and how sugar affects the liver
This Phase 2 study tests how semaglutide (a diabetes medication also used for weight) affects fatty liver and the liver’s response to sugar. It may help people with non-alcoholic fatty liver disease understand whether the drug improves liver fat and related changes.
Bethesda, MarylandAges 18–100 - NCT06795581RecruitingPhase 1
Brain imaging study for alcohol use disorder
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with alcohol use disorder. The goal is to better understand how alcohol affects the brain, which may lead to new treatments.
Bethesda, MarylandAges 18–70 - NCT03407079RecruitingPhase 2
Study of sucralose’s effects on digestion of drugs
This study tests whether the sugar substitute sucralose changes how your body absorbs and breaks down certain medicines. You’d take sucralose or a placebo for 4 weeks, visit the clinic, and complete required samples and medicine doses during visits.
Bethesda, MarylandAges 18–60 - NCT05677321Recruiting
Study how taste and smell differ in alcohol use disorder
This study compares how people with alcohol use disorder and people without it experience taste and smell. It also checks brain activity during taste/smell testing to understand individual differences that may be linked to alcohol use.
Bethesda, MarylandAges 18–65 - NCT06269627RecruitingPhase 4
Brain activity study for alcohol use treatment
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
Bethesda, MarylandAges 21–65 - NCT07046819RecruitingPhase 2
Tirzepatide for liver disease linked to alcohol use
This trial tests if tirzepatide, a medication that helps with weight and blood sugar, can improve liver health in people with alcohol use disorder who also have fatty liver disease. It aims to reduce liver fat and related risks.
Bethesda, MarylandAges 21–100 - NCT02108054Recruiting
Building and testing tasks to measure brain and movement
This study helps create and test simple tasks that measure brain function and movement in people with different backgrounds. It may help researchers better understand how the brain and body work, which can improve future alcohol-related treatments.
Bethesda, MarylandAges 18–65 - NCT03294460RecruitingPhase 1
Genetic study of smoking and alcohol response in healthy adults
This Phase 1 study tests whether certain genes linked to nicotine receptors affect how people feel and respond to alcohol. It also compares alcohol responses in smokers versus non-smokers using brain imaging (MRI) and alcohol-earning/reward tasks, aiming to better understand why some people may crave alcohol more than others.
Bethesda, MarylandAges 21–60 - NCT02108080Recruiting
Study of brain imaging in people with alcohol use disorder
This study collects natural history information and brain imaging (MRI) using an imaging instrument to compare people with alcohol use disorder and people without. It may help researchers understand how brain imaging works in real-world participants and how it relates to alcohol-related health.
Bethesda, MarylandAges 18 years+ - NCT06819189RecruitingPhase 1
How a gene affects alcohol response
This study looks at how a specific gene (ZIP8) affects the way people respond to alcohol. You'll have MRI brain scans and may be given alcohol to see how your brain reacts. It's for healthy right-handed adults of European ancestry who have some drinking experience.
Bethesda, MarylandAges 21–60 - NCT06484075RecruitingPhase 1/Phase 2
Suvorexant for alcohol use disorder: brain effects
This study tests whether the sleep medication suvorexant can help people with alcohol use disorder by looking at its effects on brain activity. Participants will stay in the hospital for about a month, take suvorexant or a placebo, and have brain scans.
Bethesda, MarylandAges 18–75 - NCT04391816Recruiting
Study of how alcohol use changed during the COVID-19 pandemic
This study follows people over time to understand how the COVID-19 pandemic affected alcohol use and related health or behaviors. You may help by answering short surveys by phone or online on a regular schedule.
Bethesda, MarylandAges 18–100 - NCT07027839RecruitingPhase 1
Alcohol effects on brain imaging for phosphodiesterase
This study uses PET scans to see how alcohol affects a protein in the brain called PDE4B. It may help explain how alcohol works in the body.
Bethesda, MarylandAges 21–70 - NCT04714892Recruiting
Taste and smell differences in obesity
This study looks at how taste and smell may differ in people with obesity compared to healthy-weight individuals. It aims to understand why some people perceive flavors differently, which could help develop better treatments for weight management.
Bethesda, MarylandAges 18–65 - NCT07191561Recruiting
Liver fat and alcohol use disorder study
This trial looks at how the liver processes fat in people with alcohol use disorder. It may help find better ways to treat liver problems related to drinking.
Bethesda, MarylandAges 18–100 - NCT04781322RecruitingPhase 1
Study drug to reduce LDL cholesterol effects in heavy drinkers
This Phase 1 study tests how safe a cholesterol-lowering antibody (alirocumab) is in people who drink heavily but are not seeking alcohol treatment. It also looks at early drug effects in the body to see how it might change cholesterol-related signals.
Bethesda, MarylandAges 21–65 - NCT02231840Recruiting
Study of how alcohol use changes over time
This study follows people over time to understand how alcohol use develops and changes. It may help researchers learn what factors are linked to changes in drinking, and it involves genetic testing and an MRI scan.
Bethesda, MarylandAges 18–100 - NCT07096271Recruiting
Relationship education for military couples
This study tests a relationship education program designed for military couples. It aims to help couples strengthen their bond and improve communication through a retreat.
Bethesda, MarylandAges 18 years+ - NCT07559500RecruitingPhase 1
Study of tirzepatide for alcohol use disorder
This trial tests if tirzepatide, a diabetes drug, affects brain chemistry linked to alcohol use. Researchers want to see if it can help people with mild-to-moderate alcohol use disorder who also have tried stimulants.
Bethesda, MarylandAges 21–65
Hear when a new Alcoholism trial opens near Washington, D.C., DC
We’ll email you when one opens near Washington, D.C., DC — at most once a week, no account needed, unsubscribe anytime.
Alcoholism trials in other cities
Where these studies are running near Washington, D.C.
Institutions with a site for the recruiting alcoholism studies listed above.
- National Institutes of Health Clinical Center · 20 studies
- Georgetown University Medical Center
- Johns Hopkins Hospital
- Mercy Medical Center
- National Institute on Alcohol Abuse and Alcoholism
- Uniformed Services University of the Health Sciences
- Washington DC VA Medical Center
What taking part in a alcoholism study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Common questions
- Are there alcoholism clinical trials near Washington, D.C.?
- Yes. We're currently tracking 43 recruiting alcoholism studies with a site near Washington, D.C., each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a alcoholism study near Washington, D.C.?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Washington, D.C. to take part?
- Not necessarily. These studies have a site near Washington, D.C., but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a alcoholism trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New alcoholism studies open near Washington, D.C. regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.